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Abstract 
This paper aims to assess the current state of knowledge about the use of L - cysteine in food industry, regarding 
certain cultural, legal, technological, toxicological, and other aspects that influence the attitude of the consumers 
towards  food.  Use  of  L  -  cysteine  and  its  derivatives  in  bakery  allows  the  optimizing  of  the  technological 
characteristics of flours and their higher recovery, by using products with high added value. Use the E 920 additive 
in human food is subject to the cultural and religious controversy, due to the generalized process of obtaining this 
additive  from animal products (keratin). Our study shows that these controversies will be overcome when industrial 
fermentative technologies of L - cysteine production  will be generalized in the market. There exist no data on the 
potential toxicity of L - cysteine in the usual doses which are used in the baking industry. The only threat to the 
status of E 920 as a safe additive is the excitotoxic potential, suggested in several recent studies. Also, there exists a 
potential for extending the use of L - cysteine in the food industry in order to reduce the contamination degree with 
certain chemicals having carcinogen potential, such as acrylamide and mycotoxins. 
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INTRODUCTION  
A brochure entitled "25 Amazing Facts about 
food"  was  published  in  2011,  under  the 
signatures  of  Mike  Adams  and  David 
Guiterrez  and  the  copyright  of  Truth 
Publishing Inc. This brochure makes several 
statements about some additives used in food 
industry;  that  have  enjoyed  significant 
notoriety  in  the  Romanian  online 
environment.  Thus,  the  authors  make  the 
following  statements  about  one  of  the 
additives used in the baking industry: While 
some  L-cysteine  is  directly  synthesized  in 
laboratories,  most  of  it  is  extracted  from  a 
cheap and abundant natural protein source: 
human hair. The hair is dissolved in acid and 
L-cysteine  is  isolated  through  a  chemical 
process. Other sources of L-cysteine include 
chicken  feathers,  duck  feathers,  cow  horns 
and petroleum byproducts [1]. 
This paper aims to assess the current state of 
knowledge about the use of this amino acid in 
nutrition,  regarding  the  most  important 
aspects which influence the market, namely: 
cultural,  legal,  technological,  toxicological, 
etc. 
 
MATERIALS AND METHODS  
 
In order to assess the main aspects of using L 
-  cysteine  aminoacid,  there  have  been 
extensively  studied  a  series  of  bibliographic 
databases  including  the  European 
Commission's  legislative,  public  opinion 
experts EFSA scientific articles in the fields 
of food technology, biochemistry, toxicology, 
nutrition,  medical  science  market  research, 
and  opinions  of  Jewish  religious  texts 
scholars. 
 
RESULTS AND DISCUSSIONS 
 
Cysteine  has  been  isolated  in  1810  by 
Wollaston from kidney stones. It is found in 
variable  proportions  in  different  plant  and 
animal proteins (0.8% in zein, 2.3% in wheat 
gliadin,  12.5%  in  insulin,  1.1%  in  muscle 
proteins, etc.). Scientific Papers  Series  Management , Economic Engineering in Agriculture  and Rural Development  
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L-cysteine and its derivatives are widely used 
in baking, in quantities up to 90 ppm. Efectele 
Effects  of  cysteine  addition  to  flour  are 
obvious  in  the  increasing  of  the  fluid 
properties of dough: it decreases its ability of 
accumulating  energy,  toughness  and 
resistance  to  extension,  and  increases  its 
adhesiveness and extensibility [2]. 
Flours which require the addition of reducing 
agents  generally  give  products  with  small 
volume, dense core, undeveloped porosity and 
poor flavor [16]. 
There is an intense controversy in the Western 
world on the use of L-cysteine in bakery. It is 
not based on the potential adverse effects to 
human health, but on the assumption that its 
origin  is  opposed  to  the  vegan  food 
philosophy  and  the  Muslim  Sharia 
requirements.  Mosaic  worship  expressed 
through  an  analysis  made  by  a  rabbi,  an 
interesting opinion on the use of L - cysteine 
in diet. 
L-cysteine was considered "kosher" provided 
that it does not come from human cadavers or 
have previously been the subject of a religious 
sacrifice [17].  
Some properties of foods rich in cysteine were 
known and used since talmudic times. Gemara 
(one of the books of Talmud) relates that Rav 
Abbah  (175-247)  using  a  recipe  based  on 
chicken macerate for medicinal purposes and, 
in  the  Middle  Ages,  Rambam  (1135-1204) 
prescribed to  Prince Al- Afdal from the court 
of  Saladin  a  similar  recipe  for  asthma 
treatment (treatment of this disease is also in 
use today, using derivatives of cysteine) [17]. 
Despite  this,  many  Hebrew  internet  sites 
consider food containing L - cysteine as "non-
kosher". 
L-cysteine is not the only food additive in this 
situation.  Similar  controversies  concern  the 
gelatin,  rennet  used  in  the  cheese  industry, 
bone  powder  used  to  whiten  sugar 
sporadically,  frosting  agents  such  as  shellac 
and beeswax, and red colors of cochineal. 
L-cysteine global market is estimated at 5000 
tons per year and is supplied as a result of a 
mixture of different production technologies, 
which  include  keratin  hydrolysis,  chemical 
synthesis and fermentation (Fig. 1) [6, 13]. 
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Fig. 1 Global market of L - cysteine (tonnes) 
 
Although  for  most  amino  acids  there  have 
been developed biosynthetic technologies, the 
major  route  for  obtaining  L  cysteine,  L  - 
Leucine,  L  -  histidine  and  L  -  tyrosine 
remained  the  extraction  from  protein 
hydrolysates.  As  for  cysteine,  it  is  used  the 
extraction from hydrolyzed keratin, obtained 
from human hair or feathers of animals [22]. 
Among the biosynthesis technologies used on 
an  industrial  scale  we  emphasize  the  
biosynthesis  technology  used  by  Ajinomoto 
Co..  Inc.,  Japan,  which  involves  the 
asymmetric hydrolysis DL - 2 - amino-Δ2 - 
tiazolin - 4-carboxylic acid to L - cysteine, 
using  enzymes  secreted  by  bacteria  of  the 
genus  Pseudomonas.  Also,  Wacker  Chemie 
(2001) implemented an industrial method for 
obtaining  L  -  cysteine  via a mutant  E. coli, 
using glucose as the main carbon source [14]. 
Market value of L - cysteine is estimated at 55 
million dollars, with a growth rate of 4% per 
year  [14].  Approximately  30%  of    the 
worldwide produced  L  - cysteine is  used to 
obtain its pharmacotherapeutic derivatives (N-
acetylcysteine  and  S-carboximetilcysteine, 
both having mucolytic action). 
In addition to the use of L - cysteine as flour 
treatment agent in bakery industry, is it also 
used  extensively  in  food  animal  production 
industry. Its role in animal feed isto enrich the 
beef  flavor  of  these  products.  A  lower  but 
constant  consumption  is  recorded  in  the 
cosmetic industry, as a basic preparate in anti-
aging creams. 
Of all the L - cysteine produced worldwide, in 
2004, only 12% was obtained by fermentation 
processes. Annual growth rate for the market 
share of microbial L-cysteine was estimated at 
10%. 
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obtaining involves the acid hydrolysis (HCl> 
20%) of keratin at high temperatures (100 
0C 
for  6  hours).  The  process  has  certain 
environmental  implications,  which  are 
difficult  to  manage.  In  order  to  obtain  one 
kilogram  of  cysteine,  there  are  required  27 
kilograms of hydrochloric acid; this involves 
the use of big water resources. Comparitively, 
the  biosynthesis  method  applied  by  Wacker 
Chemie  requires  only  1  kilogram  of 
hydrochloric acid to obtain one kilogram of L 
- cysteine. Despite this, L - cysteine obtained 
by  fermentation  is  more  expensive  than  the 
conventional one and is preferred primarily by 
pharmaceutical and cosmetic industries. This 
industries  are  able  to  transfer  these  costs  to 
products  with  higher  added  value  than  food 
industry. 
One of the factors that determine the interest 
of the pharmaceutical industry for microbial L 
-  cysteine  is  the  fear,  deeply  rooted  in  the 
psychology  of  consumers,  on  the  risks 
involved  in  the  consumption  of  certain 
products of animal origin, having the capacity 
of  transmitting  prion  diseases  such  as 
Creutzfeldt  -  Jakob  disease  (spongiform 
encephalopathy). 
The  European  Commission  experts  have 
analyzed this issue in 2000, at the request of 
some  producers’  organizations  in  the 
cosmetics  industry.  They  asked  for  the 
changing of the Directive 76/768/EEC which 
prohibitted the use of cells, tissues or products 
of  human  origin  in  the  manufacture  of 
cosmetics sold in the Common Market, so that 
the amino acids obtained by acid hydrolysis of 
keratin can still be used. 
The experts’ conclusion was that amino acids 
obtained  by  hydrolysis  of  keratin  can  be 
considered  safe  for  human  consumption,  as 
long as they are not contaminated with other 
substances with high risk of transmission of 
human spongiform encephalopathies (TSEs). 
The  conclusion  was  based  on  the  following 
assumptions,  which  can  be  extrapolated  to 
food: prions associated with TSE have never 
been identified in hair; the obtaining process 
involves  a  series  of  inactivation  conditions 
that reduce the number of infectious units at a 
lower level even than the level already agreed 
by the EU legislation regarding manufacturing 
of food gelatine; severe hydrolysis conditions 
in  combination  with  mandatory  tests, 
regarding the lack of peptides in L - cysteine 
based preparates, can guarantee the exclusion 
of transmissible prion protein from them [26]. 
The  European  Commission  experts  were 
called  to  respond  later  (2006)  to  questions 
about the safety of adding this amino acid to 
biscuits for young children (3 to 12 months). 
Although this amino acid has been approved 
for  use  in  treating  flour,  the  assessments 
considering  it  toxicologically  acceptable,  it 
was not mentioned in the list of food additives 
accepted  in  the  food  formulation  for  babies 
and toddlers. Biscuits for children should have 
a controlled content of carbohydrates and fat. 
But  this  fact  leads  to  increased  fragility  of 
biscuits,  inducing  additional  risk  of 
suffocation.  Use  of  L  -  cysteine  or  its 
hydrochloride  derivative  product  enables 
optimization  of  textural  characteristics  of 
crunchy products and reduces the mentioned 
risk. 
The usual dose of L - cysteine is max. 1 g / kg 
flour. Extrapolated to the average quantities of 
biscuits  consumed  daily  by  a  toddler,  the 
amount of cysteine intake is the equivalent to 
6 mg / day. This amount represents only 2% 
of the total cysteine provided to a child by his 
entire daily diet (296 mg). 
Consequently, the group of experts concluded 
that the use of L - cysteine in baby products 
present no risk to their safety and that is not in 
contradiction with previous recommendations 
of the European Commission. 
Recommendation  stated  that  the  addition  of 
amino acids in the diet of children should be 
performed  only  in  order  to  improve  its 
nutritional value [25]. 
Previous  explanation  can  be  applied  for 
exposure  adults  to  this  amino  acid  after  the 
consumption  of  bakery  products.  Accurate 
assessment of the amounts of L - cysteine or 
its derivatives, provided by the mill - bakery 
food chain is quite difficult. On one hand, L-
cysteine is added to the mill, and on the other 
hand, improvers used in bakeries contain also 
varyous amounts of L - cysteine. We suspect a 
linear  correlation  between  the  value  of  this 
consumption  and  the  quality  of  Romanian 
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kilogram  of  flour  is  unlikely  to  exceed  an 
average of 0.05 to 0.1 grams. Quantities of L - 
cysteine  may  be  much  higher  for  biscuits 
which have dough rheological characteristics 
adjusted  to  the  required  values  for  the 
manufacturing processes,  by treatments with 
proteases  and  reducing  agents.  The  average 
daily  consumption  of  bread  per  capita  was 
estimated by Econtext.ro for 2010 to 0.26 kg 
[19]. If we assume that the average specific 
consumption is 0.75 kg of flour per kilogram 
of finished product, then the  amount of  L-
cysteine corresponding to this consumption is 
9.75 to 19.5 milligrams. Namely, the amount 
of  L-cysteine is 25 - 50 times lower than the 
usual  daily  amount  of  L-cysteine  or  its 
derivatives used for therapeutic purposes, for 
treating various diseases (fig 2). 
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Fig.  2  Daily  doses  of  L  -  cysteine  associated  with 
several components of the diet or medication 
 
New directions for the use of L-cysteine in 
the food industry. 
In  recent  year  there  have  been  patented 
several  methods  which  use  L  -  cysteine  or 
thiol compounds for reducing the acrylamide 
content  in  foods.  Acrylamide  is  a  potential 
carcinogenic  substance  that  is  formed  when 
starchy foods are baked, boiled or roasted. 
Flukiger  and  Salih  suggested  in  2009  a 
method for treating food to be cooked with an 
alkaline  solution  of  cysteine  or  glutathione. 
Thiol  compounds  in  alkaline  solution  react 
with  acrylamide,  through  the  carbon  double 
bonds in its molecule, forming a new nontoxic 
compound  [11].  Barry  et  al.  suggested 
previously  a  similar  method,  involving  food 
contact  before  the  heat  treatment  with  a 
solution composed from calcium chloride and 
L - cysteine [3]. 
Other  studies  have  shown  similar  effects  of 
inhibition  of  the  acrylamide  formation  in 
aqueous  systems  and  in  vivo,  when  certain 
embryos were exposed to high concentrations 
of acrylamide [8, 18, 7]. 
Since  thiol  compounds  are  potent 
nucleophiles, they have a strong affinity  for 
the  unsaturated  electrophilic  centers  of 
different  dietary  toxicants  in  food,  such  as 
aflatoxins,  sesquiterpenes,  lactones 
(elephantropin  and  parthenin),  urethane, 
carbonyl  compounds,  quinones  and  even  , 
halogenated compounds [6]. Boyacioğlu et al. 
published  in  1993  a  study  showing  that  in 
particular  L  -  cysteine  has  a  moderate 
decrease  in  DON  content  of  whole  wheat 
bread.  Along  with  sodium  bisulphite 
ammonium  phosphate,  treatment  with  L  - 
cysteine ensured a reduction of DON content 
between  38  and  46%  [5].  A  cysteine 
derivative, namely N-acetylcysteine at a dose 
of 800 mg / kg of forage, was able to reduce 
the toxic effects of aflatoxin B, when added to 
chickens diet [21]. 
Cysteine  and  glutathione  are  part  of  the 
substances  able  to  stop  the  formation  of 
nitrosamines  produced  endogenously  in  the 
stomach  and  digestive  tract,  such  as:  N-
nitrosodimethylamine,  N-nitroso-N-
nitrosopiperidin  and  N-nitrosopyrrolidine 
[20]. 
Toxic effects of L - cysteine in the body.  
Potential toxic effects of L-cysteine have been 
tested  on  rats  since  the  '70s.  The  results 
published  in  the  Journal  of  the  Science  of 
Food  and  Agriculture,  showed  that  despite 
feeding  rats  with  bread  made  from  flour 
treated with doses of 10 to 100 times higher 
than  usual  doses,  there  have  not  been 
identified histopathological changes or injury 
in the body to fifth generation [12]. 
However, some studies have shown that L - 
cysteine  may  have  negative  effects  on  the 
animal organism when it is administrated in 
very high doses. Dilger et al. introduced feed 
treated with 30 g / kg L-cysteine in chickens’ 
diet  and  identified  certain  changes  in  their 
health  status,  as  well  as  metabolic  acidosis 
and increased oxidative stress in the body [9]. Scientific Papers  Series  Management , Economic Engineering in Agriculture  and Rural Development  
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In  a  previous  study,  they  investigated  the 
effects of supplementing the diet with extreme 
amounts  of  sulfur  amino  acids  in  several 
species. They found that excess L - cysteine in 
doses  of  7.5  times  higher  than  dietary 
recommendations may result after five days of 
dosing in increased mortality by 50%. In all 
variants  of  administration  (2.5  -  10  times 
more  than  the  dietary  recommendations), 
taking L - cysteine suppressed the growth of 
chickens. 
In young mice or pigs receiving similar doses 
of L - cysteine, were not identified significant 
changes  in  mortality,  but  growth  has  been 
drastically suppressed. For none of the three 
analyzed species there have not been related 
similar  symptoms  to  cystine  excess  in  food 
[10]. 
 In the literature there are cited a series of L-
cysteine  interferences  with  the  therapeutic 
medication,  administered  in  case  of  illness. 
Thus, L - cysteine potentiates the activity of 
the drugs used to lower blood pressure. It also 
can  cause  suppression  of  immunity,  thereby 
increasing  susceptibility  to  certain  diseases 
[27]. 
There have been reported situations where L - 
cysteine  inactivated  the  insulin  given  to 
diabetics. However, it is considered that L – 
cysteine  potentiates  the  toxicity  of  sodium 
monoglutamate,  for  the  Chinese  restaurants 
disease  sufferers  [28].  For  the  patients 
suffering  from  cystinuria,  the  administration 
of  L- cysteine has a negative effect. 
Several  views  include  L  -  cysteine  in 
excitotoxins  category.  These  are  substances 
that  have  physiological  functions  of 
neurotransmitters  (usually  amino  acids  or 
derivatives  thereof),  and  can  supraactivate 
specific receptors in the nerve cell when they 
have  high  concentrations.  The  process 
consists of an excessive stimulation of nerve 
cells,  which  can  result  in  their  destruction. 
The  best  known  substance  with  excitotoxic 
effect is sodium monoglutamate. 
In  1990  Olney  et  al.  found  that  systemic 
administration of L-cysteine to immature mice 
correlates  with  destruction  of  nerve  cells  in 
the  cerebral  cortex,  hippocampus,  thalamus 
and  striatum.  The  author's  opinion  is  that 
neurotoxicity of L - cysteine is also mediated 
by glutamate receptors (subtype N-Methyl-D-
aspartate) and its magnitude increases in the 
presence of bicarbonate ions at physiological 
concentrations [15]. 
The chemical reactivity of the thiol group of L 
-  cysteine  can  induce  toxicity  by 
autooxidation,  through  formation  of  reactive 
oxygen species [23]. 
Many doubts about the toxic potential of L - 
cysteine are induced by associating the high 
level  of  of  homocysteine  in  the  body  with 
some  neurodegerative  and  cardiovascular 
diseases. Homocysteine is involved in many 
transsulfuration  reactions  (such  as  cysteine 
synthesis in the body), remethylation (in the 
synthesis  of  methionine),  transmetilation  of 
DNA,  proteins  and  lipids,  biosynthesis  of 
certain  neurotransmitters  or  hormones. 
Homocysteine oxidizes many analogues of L - 
glutamate    (L  –homocyisteinsulfinic  acid, 
homocysteic  acid)  and  L  -  aspartate  (L-
cisteinsulfinic  acid,  cisteic  acid)  that  exert 
excitotoxic  effects  even  greater  than  the 
excitotoxic  effect  of  homocysteine  [4]. 
Homocysteine  enhances  LDL  autooxidation 
lipoprotein  particles,  thus  initiating 
thrombosis or atheroma plaque buildup. 
 
CONCLUSIONS 
 
1. Use of L - cysteine and its derivatives in 
bakery  allows  the  optimizing  of  the 
technological  potential  of  flours  and  their 
superior  use,  by  products  with  high  added 
value.  Controversies  surrounding  the  use  of 
additives  in  food  are  primarily  cultural  and 
religious  controversies  and  are  likely  to  be 
exceeded when the fermentative technologies 
for producing L - cysteine will generalize in 
the market. 
2. There is potential to extend the use of L - 
cysteine  in  the  food  industry,  to  reduce 
contamination  with  potentially  carcionogen 
number of substances such as acrylamide and 
mycotoxins. 
3. There are no data on the potential toxicity 
of L - cysteine on the usual doses which are 
used in the baking industry. In medicine, L - 
cysteine  and  its  derivatives  are  used  in 
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4. The excitotoxic potential of L - cysteine is 
the biggest threat to the "sure additive " status 
of L - cysteine. Although the mechanisms of 
glutamate receptors present on nerve cells are 
not  well  understood,  the  number  of  studies 
that  gather  evidence  in  favor  of  excitotoxic 
potential of L - cysteine is growing. However, 
it is not yet clear to what extent the quantities 
of  L  -  cysteine  added  to  food  during 
processing, can interfere in these mechanisms. 
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